Use of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one in the treatment of cancer in moderate hepatic impaired patients

• 收藏
• 分享

专利权人:

Novartis AG

发明人:

Anand, Suraj Prakash,Reddick, Catherine Wynnette,Shi, Michael,Steed, Mary Ellen,Tan, Eugene Youchin,Wang, Yongyu,Stegert, Mario Reinhard

申请号：

AU2012308993

公开号：

AU2012308993A1

申请日:

2012.09.07

申请国别(地区):

AU

年份:

2014

代理人:

摘要：

The present invention relates to a method of treating a cancer in patient in need thereof by administering 4-amino-5 fluoro-3 -[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one, or a tautomer thereof, or a salt of any one of them, wherein the patient is a moderate hepatic impaired patient.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/